ELOXX PHARMACEUTICALS, INC. (ELOX) Free cash flow 2016–2022
ELOXX PHARMACEUTICALS, INC. (ELOX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$31.9MFY2022 · since FY2016: -$1.9M → -$31.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$31.9M | +9.1% |
| FY2021 | -$35.1M | — |
| FY2019 | -$39.4M | -24.8% |
| FY2018 | -$31.6M | -95.4% |
| FY2017 | -$16.2M | -739.0% |
| FY2016 | -$1.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ELOX financial trends
ELOX RevenueELOX Net incomeELOX Net marginELOX Gross profitELOX Gross marginELOX Operating incomeELOX Operating marginELOX Operating cash flowELOX Capital expendituresELOX Return on equityELOX Stock buybacksELOX Dividends paidELOX Total assetsELOX Total liabilitiesELOX Shareholders’ equityELOX overview →